<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:sdc="http://www.alacra.com/sdc" xmlns:bir="http://www.alacra.com/bir" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:spcred="http://www.alacra.com/spcred" xmlns:srp="http://www.alacra.com/srp" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>inVentiv Health Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>inVentiv Health Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/inVentiv_Health_Inc-2102440</link>
<lastBuildDate>Friday, January 09, 2009 7:59:12 AM</lastBuildDate>
<alacra:xlsid>2102440</alacra:xlsid>
<alacra:company>inVentiv Health Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/bir/966321</link><guid isPermaLink="false">bir/966321</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>inVentiv Health Inc.</title><bir:company xmlns:bir="http://www.alacra.com/bir">inVentiv Health Inc.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">Ventiv Health Inc.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">Snyder Healthcare Services Inc.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">Franklin Group Inc.</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Services: Provider of sales and marketing services.</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">8742</bir:sic><bir:naics xmlns:bir="http://www.alacra.com/bir">541611</bir:naics><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">H</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">J</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">VTIV</bir:ticker><pubDate>11/19/2008 6:32:13 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">966321</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T2000903</link><guid isPermaLink="false">ccbn/T2000903</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good morning, ladies and gentlemen, welcome to the inVentiv Health Inc. Third Quarter #### Conference Call. I would like to inform you that this conference is being recorded and that all participants are in a listen-only mode. After the speakers' remarks, there will be a question-and-answer period. (Operator Instructions) You will kindly refer to the risk factors and cautionary language contained in the documents that the Company filed with the Securities and Exchange Commission, including particularly [part one], item #A of the Company's #### annual report on Form ##-K. It should be noted that financial and statistical information that is discussed during the call and the reconciliation of non-GAAP financial measures discussed to their comparable GAAP financial measures is available at the Investor Relations portion of the Company's website at www.inventivhealth.com. The Company would also like to refer investors to the supplemental investors' slide packet, which has been included in the...

</description><pubDate>11/6/2008 4:07:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">inVentiv Health, Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">inVentiv Health, Inc. Q3 2008 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">VTIV</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>inVentiv Health, Inc. Q3 2008 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T2000903</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PZM-0001-29298977</link><guid isPermaLink="false">newstex/PZM-0001-29298977</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Nov. #, #### (GlobeNewswire delivered by Newstex) -- *  Third Quarter Total Revenues Up ##% to $###.#mm; Net Revenues      Up ##% to $###.#mm   *  Third Quarter Adjusted EPS of $#.##; GAAP EPS of $#.##   *  Strong Cash Flow from Operations...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><pubDate>11/6/2008 8:25:32 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18016000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">GlobeNewswire</newstex:Publication><title>inVentiv Health Reports Financial Results for Third Quarter 2008</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PZM-0001-29298977</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">inVentiv Health, Inc.</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">VENTIV HEALTH INC</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">Blane Walter</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">VTIV</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1902629</link><guid isPermaLink="false">ccbn/T1902629</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good morning, ladies and gentlemen. Welcome to the inVentiv Health, Incorporated second quarter #### conference call. I would like to inform you that this conference is being recorded and that all participants are in listen-only mode. After the speakers' remarks, there will be a question-and-answer period. (OPERATOR INSTRUCTIONS) Before we begin, I would like to read the following regarding forward-looking statements. During the course of this conference call, the Company may make projections or other forward-looking statements regarding the financial performance of the Company. Such forward-looking statements involve known and unknown risk that may cause the Company's performance to differ materially. You are kindly referred to the risk factor and cautionary language contained in the documents that the Company filed with the Securities and Exchange Commission, including particularly Part #, Item #a, of the Company's #### annual report on Form ##-K. It should be noted that financial and...

</description><pubDate>8/7/2008 2:07:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">inVentiv Health, Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">inVentiv Health, Inc. Q2 2008 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">VTIV</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>inVentiv Health, Inc. Q2 2008 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1902629</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><title>inVentiv Health Inc acquires Patient Marketing Group Inc (pending)</title><description>US - inVentiv Health Inc definitively agreed to acquire Patient Marketing Group, a provider of pharmaceutical marketing services, for $##.# mil in cash an up to an undisclosed amount in profit-related payments.</description><pubDate>8/5/2008 1:35:37 PM</pubDate><sdc:company_cusip xmlns:sdc="http://www.alacra.com/sdc">46122E</sdc:company_cusip><sdc:target_company_cusip xmlns:sdc="http://www.alacra.com/sdc">70315A</sdc:target_company_cusip><sdc:company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">46122E</sdc:company_cusip_up><sdc:target_company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">70315A</sdc:target_company_cusip_up><sdc:company xmlns:sdc="http://www.alacra.com/sdc">inVentiv Health Inc</sdc:company><sdc:target_company xmlns:sdc="http://www.alacra.com/sdc">Patient Marketing Group Inc</sdc:target_company><sdc:company_up xmlns:sdc="http://www.alacra.com/sdc">inVentiv Health Inc</sdc:company_up><sdc:target_company_up xmlns:sdc="http://www.alacra.com/sdc">Patient Marketing Group Inc</sdc:target_company_up><link>http://www.alacrastore.com/storecontent/Thomson_M%26A/inVentiv_Health_Inc_acquires_Patient_Marketing_Group_Inc-2001486020</link><guid isPermaLink="false">sdc/2001486020</guid><sdc:deal xmlns:sdc="http://www.alacra.com/sdc"><sdc:deal_no>2001486020</sdc:deal_no><sdc:_copyright><sdc:value>Copyright Â© 2008, Thomson Financial, All Rights Reserved</sdc:value></sdc:_copyright><sdc:a_EXCHANGE><sdc:value>Nasdaq</sdc:value></sdc:a_EXCHANGE><sdc:a_MAINDUSTRY><sdc:value>Business Services</sdc:value></sdc:a_MAINDUSTRY><sdc:a_NATION><sdc:value>United States</sdc:value></sdc:a_NATION><sdc:a_SICDESC><sdc:value>Management consulting services</sdc:value></sdc:a_SICDESC><sdc:a_SICPI><sdc:value>8742</sdc:value></sdc:a_SICPI><sdc:a_STATE><sdc:value>NJ</sdc:value></sdc:a_STATE><sdc:a_STATELONG><sdc:value>New Jersey</sdc:value></sdc:a_STATELONG><sdc:a_STATUS><sdc:value>Public</sdc:value></sdc:a_STATUS><sdc:a_TICKER><sdc:value>VTIV</sdc:value></sdc:a_TICKER><sdc:asic_SIC><sdc:value sdc:p="0">7311:Advertising agencies</sdc:value><sdc:value sdc:p="1">7361:Employment agencies</sdc:value><sdc:value sdc:p="2">7389:Business services, nec</sdc:value><sdc:value sdc:p="3">8732:Commercial nonphysical research</sdc:value><sdc:value sdc:p="4">8742:Management consulting services</sdc:value></sdc:asic_SIC><sdc:aupsic_SIC><sdc:value sdc:p="0">7311:Advertising agencies</sdc:value><sdc:value sdc:p="1">7361:Employment agencies</sdc:value><sdc:value sdc:p="2">7389:Business services, nec</sdc:value><sdc:value sdc:p="3">8732:Commercial nonphysical research</sdc:value><sdc:value sdc:p="4">8742:Management consulting services</sdc:value></sdc:aupsic_SIC><sdc:b_MAINDUSTRY><sdc:value>Business Services</sdc:value></sdc:b_MAINDUSTRY><sdc:b_NATION><sdc:value>United States</sdc:value></sdc:b_NATION><sdc:b_SICDESC><sdc:value>Management consulting services</sdc:value></sdc:b_SICDESC><sdc:b_SICPI><sdc:value>8742</sdc:value></sdc:b_SICPI><sdc:b_STATE><sdc:value>NJ</sdc:value></sdc:b_STATE><sdc:b_STATELONG><sdc:value>New Jersey</sdc:value></sdc:b_STATELONG><sdc:b_STATUS><sdc:value>Private</sdc:value></sdc:b_STATUS><sdc:c_ACIDGEN><sdc:value>595531003</sdc:value></sdc:c_ACIDGEN><sdc:c2up_BUSS><sdc:value>Pvd sales,mktg svcs</sdc:value></sdc:c2up_BUSS><sdc:c3up_BUSS><sdc:value>Pvd pharm mktg svcs</sdc:value></sdc:c3up_BUSS><sdc:co_DESCR><sdc:value sdc:p="0">Cash</sdc:value><sdc:value sdc:p="1">Earnout</sdc:value></sdc:co_DESCR><sdc:cs_DESCR><sdc:value>Assets</sdc:value></sdc:cs_DESCR><sdc:d_TCIDGEN><sdc:value>1032515001</sdc:value></sdc:d_TCIDGEN><sdc:date_lastupdate><sdc:value>Aug 5 2008</sdc:value></sdc:date_lastupdate><sdc:finbltm_BV><sdc:value>0.00000</sdc:value></sdc:finbltm_BV><sdc:finbltm_CASH><sdc:value>0.00000</sdc:value></sdc:finbltm_CASH><sdc:finbltm_CASHFLOW><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW><sdc:finbltm_CASHFLOW1><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW1><sdc:finbltm_CASHFLOW2><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW2><sdc:finbltm_CASHFLOW3><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW3><sdc:finbltm_CASHFLOW4><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW4><sdc:finbltm_CASHFLOW5><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW5><sdc:finbltm_COMEQ><sdc:value>0.00000</sdc:value></sdc:finbltm_COMEQ><sdc:finbltm_DEBTRAT><sdc:value>0.00000</sdc:value></sdc:finbltm_DEBTRAT><sdc:finbltm_DSER2><sdc:value>0.00000</sdc:value></sdc:finbltm_DSER2><sdc:finbltm_EBIT><sdc:value>0.00000</sdc:value></sdc:finbltm_EBIT><sdc:finbltm_EPS><sdc:value>0.00000</sdc:value></sdc:finbltm_EPS><sdc:finbltm_NI><sdc:value>0.00000</sdc:value></sdc:finbltm_NI><sdc:finbltm_PTINC><sdc:value>0.00000</sdc:value></sdc:finbltm_PTINC><sdc:finbltm_SALES><sdc:value>0.00000</sdc:value></sdc:finbltm_SALES><sdc:finbltm_STDEBT><sdc:value>0.00000</sdc:value></sdc:finbltm_STDEBT><sdc:finbltm_TASS><sdc:value>0.00000</sdc:value></sdc:finbltm_TASS><sdc:fiscal_ADCR><sdc:value>0.00000</sdc:value></sdc:fiscal_ADCR><sdc:fiscal_AEPS><sdc:value>0.00000</sdc:value></sdc:fiscal_AEPS><sdc:fiscal_ANI><sdc:value>0.00000</sdc:value></sdc:fiscal_ANI><sdc:fiscal_APFDCR><sdc:value>0.00000</sdc:value></sdc:fiscal_APFDCR><sdc:fiscal_ASALES><sdc:value>0.00000</sdc:value></sdc:fiscal_ASALES><sdc:fiscal_ATASS><sdc:value>0.00000</sdc:value></sdc:fiscal_ATASS><sdc:fiscal_RATE><sdc:value>0.00000</sdc:value></sdc:fiscal_RATE><sdc:g_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value><sdc:value sdc:p="11">12.00000</sdc:value><sdc:value sdc:p="12">13.00000</sdc:value><sdc:value sdc:p="13">14.00000</sdc:value></sdc:g_SEQ><sdc:g_TEST><sdc:value sdc:p="0">inVentiv Health Inc is a</sdc:value><sdc:value sdc:p="1">provider of outsourced sales</sdc:value><sdc:value sdc:p="2">and marketing services,</sdc:value><sdc:value sdc:p="3">headquartered in Somerset, New</sdc:value><sdc:value sdc:p="4">Jersey. The company offers</sdc:value><sdc:value sdc:p="5">market research, data</sdc:value><sdc:value sdc:p="6">collection and management,</sdc:value><sdc:value sdc:p="7">recruitment, and training,</sdc:value><sdc:value sdc:p="8">clinical staffing, clinical</sdc:value><sdc:value sdc:p="9">research and statistical</sdc:value><sdc:value sdc:p="10">analysis, and executive</sdc:value><sdc:value sdc:p="11">placement for the global</sdc:value><sdc:value sdc:p="12">pharmaceutical, life sciences</sdc:value><sdc:value sdc:p="13">and biotechnology industries.</sdc:value></sdc:g_TEST><sdc:g_business><sdc:value sdc:p="0">inVentiv Health Inc is a provider of outsourced sales and</sdc:value><sdc:value sdc:p="1">marketing services, headquartered in Somerset, New Jersey.</sdc:value><sdc:value sdc:p="2">The company offers market research, data collection and</sdc:value><sdc:value sdc:p="3">management, recruitment, and training, clinical staffing,</sdc:value><sdc:value sdc:p="4">clinical research and statistical analysis, and executive</sdc:value><sdc:value sdc:p="5">placement for the global pharmaceutical, life sciences and</sdc:value><sdc:value sdc:p="6">biotechnology industries.</sdc:value></sdc:g_business><sdc:g_business1><sdc:value>inVentiv Health Inc is a provider of outsourced sales and marketing services, headquartered in Somerset, New Jersey. The company offers market research, data collection and management, recruitment, and training, clinical staffing, clinical research and statistical analysis, and executive placement for the global pharmaceutical, life sciences and biotechnology industries.</sdc:value></sdc:g_business1><sdc:h_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value></sdc:h_SEQ><sdc:h_TEST><sdc:value sdc:p="0">Patient Marketing Group is a</sdc:value><sdc:value sdc:p="1">provider of pharmaceutical</sdc:value><sdc:value sdc:p="2">marketing services,</sdc:value><sdc:value sdc:p="3">headquartered in Princeton,</sdc:value><sdc:value sdc:p="4">New Jersey. The company offers</sdc:value><sdc:value sdc:p="5">patient engagement services to</sdc:value><sdc:value sdc:p="6">global healthcare industries.</sdc:value></sdc:h_TEST><sdc:h_business><sdc:value sdc:p="0">Patient Marketing Group is a provider of pharmaceutical</sdc:value><sdc:value sdc:p="1">marketing services, headquartered in Princeton, New Jersey.</sdc:value><sdc:value sdc:p="2">The company offers patient engagement services to global</sdc:value><sdc:value sdc:p="3">healthcare industries.</sdc:value></sdc:h_business><sdc:h_business1><sdc:value>Patient Marketing Group is a provider of pharmaceutical marketing services, headquartered in Princeton, New Jersey. The company offers patient engagement services to global healthcare industries.</sdc:value></sdc:h_business1><sdc:i_AFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_AFEEPCT><sdc:i_AFEETOT><sdc:value>0.00000</sdc:value></sdc:i_AFEETOT><sdc:i_ATERMFEE><sdc:value>0.00000</sdc:value></sdc:i_ATERMFEE><sdc:i_COMOUT><sdc:value>0.00000</sdc:value></sdc:i_COMOUT><sdc:i_CROSS1><sdc:value>N</sdc:value></sdc:i_CROSS1><sdc:i_CURRENCYLONG><sdc:value>U.S. Dollar</sdc:value></sdc:i_CURRENCYLONG><sdc:i_DATEANN><sdc:value>04 Aug 08</sdc:value></sdc:i_DATEANN><sdc:i_DATEANN2><sdc:value>Mon, 04 Aug 2008 00:00:00 EST</sdc:value></sdc:i_DATEANN2><sdc:i_DATEANNS><sdc:value>Date Announced: 08/04/2008</sdc:value></sdc:i_DATEANNS><sdc:i_DATEEFFS><sdc:value>Date Effective:</sdc:value></sdc:i_DATEEFFS><sdc:i_DESCR><sdc:value>Acq. of Assets</sdc:value></sdc:i_DESCR><sdc:i_DESCR1><sdc:value>Friendly</sdc:value></sdc:i_DESCR1><sdc:i_FEEPCT><sdc:value>0.00000</sdc:value></sdc:i_FEEPCT><sdc:i_FEETOT><sdc:value>0.00000</sdc:value></sdc:i_FEETOT><sdc:i_HOSTAFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTAFEETOT><sdc:i_HOSTENTVAL><sdc:value>0.00000</sdc:value></sdc:i_HOSTENTVAL><sdc:i_HOSTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTFEETOT><sdc:i_HOSTPR><sdc:value>0.00000</sdc:value></sdc:i_HOSTPR><sdc:i_HOSTPRLABEL><sdc:value>Price/Share</sdc:value></sdc:i_HOSTPRLABEL><sdc:i_HOSTTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTTFEETOT><sdc:i_HOSTVALUE><sdc:value>14.5 U.S. Dollar</sdc:value></sdc:i_HOSTVALUE><sdc:i_HOSTVALUE1><sdc:value>14.50000</sdc:value></sdc:i_HOSTVALUE1><sdc:i_HOST_EQVAL><sdc:value>0.00000</sdc:value></sdc:i_HOST_EQVAL><sdc:i_HOST_RANKVAL><sdc:value>14.5 U.S. Dollar</sdc:value></sdc:i_HOST_RANKVAL><sdc:i_HOST_RANKVAL1><sdc:value>14.50000</sdc:value></sdc:i_HOST_RANKVAL1><sdc:i_PCTACQ><sdc:value>0.00000</sdc:value></sdc:i_PCTACQ><sdc:i_PCTOWN><sdc:value>0.00000</sdc:value></sdc:i_PCTOWN><sdc:i_PR><sdc:value>0.00000</sdc:value></sdc:i_PR><sdc:i_PR_INITIAL><sdc:value>0.00000</sdc:value></sdc:i_PR_INITIAL><sdc:i_RANKVAL><sdc:value>14.50000</sdc:value></sdc:i_RANKVAL><sdc:i_RANK_HOSTRANKVAL><sdc:value>14.5 U.S. Dollar</sdc:value></sdc:i_RANK_HOSTRANKVAL><sdc:i_RATE><sdc:value>1.00000</sdc:value></sdc:i_RATE><sdc:i_STATUS_MMC><sdc:value>N</sdc:value></sdc:i_STATUS_MMC><sdc:i_STGVAL><sdc:value>7.39300</sdc:value></sdc:i_STGVAL><sdc:i_TERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TERMFEE><sdc:i_TFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_TFEEPCT><sdc:i_TFEETOT><sdc:value>0.00000</sdc:value></sdc:i_TFEETOT><sdc:i_TTERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TTERMFEE><sdc:i_VALLIA><sdc:value>0.00000</sdc:value></sdc:i_VALLIA><sdc:i_VALNOLIA><sdc:value>14.50000</sdc:value></sdc:i_VALNOLIA><sdc:i_VALUE><sdc:value>14.50000</sdc:value></sdc:i_VALUE><sdc:j_EQVALCF><sdc:value>0.00000</sdc:value></sdc:j_EQVALCF><sdc:j_EVCF><sdc:value>0.00000</sdc:value></sdc:j_EVCF><sdc:j_EVEBIT><sdc:value>0.00000</sdc:value></sdc:j_EVEBIT><sdc:j_EVNI><sdc:value>0.00000</sdc:value></sdc:j_EVNI><sdc:j_EVSALES><sdc:value>0.00000</sdc:value></sdc:j_EVSALES><sdc:j_MPRICEBOOK><sdc:value>0.00000</sdc:value></sdc:j_MPRICEBOOK><sdc:j_PHELD><sdc:value>0.00000</sdc:value></sdc:j_PHELD><sdc:j_PSOUGHT><sdc:value>100.00000</sdc:value></sdc:j_PSOUGHT><sdc:j_RANKVALCF><sdc:value>0.00000</sdc:value></sdc:j_RANKVALCF><sdc:j_RANKVALEB><sdc:value>0.00000</sdc:value></sdc:j_RANKVALEB><sdc:j_RANKVALNA><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNA><sdc:j_RANKVALNI><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNI><sdc:j_RANKVALSALES><sdc:value>0.00000</sdc:value></sdc:j_RANKVALSALES><sdc:j_VALEB><sdc:value>0.00000</sdc:value></sdc:j_VALEB><sdc:j_VALNI><sdc:value>0.00000</sdc:value></sdc:j_VALNI><sdc:j_VALSALES><sdc:value>0.00000</sdc:value></sdc:j_VALSALES><sdc:m_AMV><sdc:value>0.00000</sdc:value></sdc:m_AMV><sdc:m_CF3YGR><sdc:value>0.00000</sdc:value></sdc:m_CF3YGR><sdc:m_CF5YGR><sdc:value>0.00000</sdc:value></sdc:m_CF5YGR><sdc:m_DCR><sdc:value>0.00000</sdc:value></sdc:m_DCR><sdc:m_ENTVAL><sdc:value>0.00000</sdc:value></sdc:m_ENTVAL><sdc:m_EPS3YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS3YGR><sdc:m_EPS5YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS5YGR><sdc:m_LTD><sdc:value>0.00000</sdc:value></sdc:m_LTD><sdc:m_MV><sdc:value>0.00000</sdc:value></sdc:m_MV><sdc:m_NETASS><sdc:value>0.00000</sdc:value></sdc:m_NETASS><sdc:m_NETASS3YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS3YGR><sdc:m_NETASS5YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS5YGR><sdc:m_NI3YGR><sdc:value>0.00000</sdc:value></sdc:m_NI3YGR><sdc:m_NI5YGR><sdc:value>0.00000</sdc:value></sdc:m_NI5YGR><sdc:n_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value></sdc:n_SEQ><sdc:n_SYNOPSIS><sdc:value sdc:p="0">US - inVentiv Health Inc</sdc:value><sdc:value sdc:p="1">definitively agreed to acquire</sdc:value><sdc:value sdc:p="2">Patient Marketing Group, a</sdc:value><sdc:value sdc:p="3">provider of pharmaceutical</sdc:value><sdc:value sdc:p="4">marketing services, for $14.5</sdc:value><sdc:value sdc:p="5">mil in cash an up to an</sdc:value><sdc:value sdc:p="6">undisclosed amount in</sdc:value><sdc:value sdc:p="7">profit-related payments.</sdc:value></sdc:n_SYNOPSIS><sdc:n_synopsis2><sdc:value>US - inVentiv Health Inc definitively agreed to acquire Patient Marketing Group, a provider of pharmaceutical marketing services, for $14.5 mil in cash an up to an undisclosed amount in profit-related payments.</sdc:value></sdc:n_synopsis2><sdc:n_synopsis3><sdc:value sdc:p="0">US - inVentiv Health Inc definitively agreed to acquire Patient Marketing Group, a</sdc:value><sdc:value sdc:p="1">provider of pharmaceutical marketing services, for $14.5 mil in cash an up to an</sdc:value><sdc:value sdc:p="2">undisclosed amount in profit-related payments.</sdc:value></sdc:n_synopsis3><sdc:n_synopsis4><sdc:value sdc:p="0">US - inVentiv Health Inc definitively agreed to acquire Patient Marketing Group, a provider of pharmaceutical marketing services, for $14.5 mil in cash an up to an undisclosed amount in profit-related</sdc:value><sdc:value sdc:p="1">payments.</sdc:value></sdc:n_synopsis4><sdc:n_synopsis5><sdc:value sdc:p="0">US - inVentiv Health Inc definitively agreed to acquire Patient Marketing Group, a provider of pharmaceutical marketing services, for</sdc:value><sdc:value sdc:p="1">$14.5 mil in cash an up to an undisclosed amount in profit-related payments.</sdc:value></sdc:n_synopsis5><sdc:q_DESCR><sdc:value>Pending</sdc:value></sdc:q_DESCR><sdc:q_HOSTANETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTANETASS><sdc:q_HOSTANILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTANILTM><sdc:q_HOSTASALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTASALESLTM><sdc:q_HOSTATASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTATASS><sdc:q_HOSTBOOKVALUE><sdc:value>0.00000</sdc:value></sdc:q_HOSTBOOKVALUE><sdc:q_HOSTCASHFLOW><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW><sdc:q_HOSTCASHFLOW1><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW1><sdc:q_HOSTCASHFLOW2><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW2><sdc:q_HOSTCASHFLOW3><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW3><sdc:q_HOSTCASHFLOW4><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW4><sdc:q_HOSTCASHFLOW5><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW5><sdc:q_HOSTCOMMONEQUITY><sdc:value>0.00000</sdc:value></sdc:q_HOSTCOMMONEQUITY><sdc:q_HOSTEBITLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEBITLTM><sdc:q_HOSTEPS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS1><sdc:q_HOSTEPS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS2><sdc:q_HOSTEPS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS3><sdc:q_HOSTEPS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS4><sdc:q_HOSTEPS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS5><sdc:q_HOSTEPSLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPSLTM><sdc:q_HOSTNETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS><sdc:q_HOSTNETASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS1><sdc:q_HOSTNETASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS2><sdc:q_HOSTNETASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS3><sdc:q_HOSTNETASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS4><sdc:q_HOSTNETASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS5><sdc:q_HOSTNI1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI1><sdc:q_HOSTNI2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI2><sdc:q_HOSTNI3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI3><sdc:q_HOSTNI4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI4><sdc:q_HOSTNI5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI5><sdc:q_HOSTNILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTNILTM><sdc:q_HOSTPTINC1><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC1><sdc:q_HOSTPTINC2><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC2><sdc:q_HOSTPTINC3><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC3><sdc:q_HOSTPTINC4><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC4><sdc:q_HOSTPTINC5><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC5><sdc:q_HOSTPTINCLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINCLTM><sdc:q_HOSTSALES1><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES1><sdc:q_HOSTSALES2><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES2><sdc:q_HOSTSALES3><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES3><sdc:q_HOSTSALES4><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES4><sdc:q_HOSTSALES5><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES5><sdc:q_HOSTSALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALESLTM><sdc:q_HOSTTASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS><sdc:q_HOSTTASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS1><sdc:q_HOSTTASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS2><sdc:q_HOSTTASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS3><sdc:q_HOSTTASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS4><sdc:q_HOSTTASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS5><sdc:q_STATUS><sdc:value>Status:Pending</sdc:value></sdc:q_STATUS><sdc:r_PE><sdc:value>-999.00000</sdc:value></sdc:r_PE><sdc:r_PE_PRINT><sdc:value>np</sdc:value></sdc:r_PE_PRINT><sdc:r_PFTMARG><sdc:value>0.00000</sdc:value></sdc:r_PFTMARG><sdc:r_PRICEBOOK><sdc:value>-999.00000</sdc:value></sdc:r_PRICEBOOK><sdc:r_PRICEBOOK_PRINT><sdc:value>np</sdc:value></sdc:r_PRICEBOOK_PRINT><sdc:r_PTINC3YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC3YGR><sdc:r_PTINC5YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC5YGR><sdc:r_ROE><sdc:value>0.00000</sdc:value></sdc:r_ROE><sdc:r_SALES3YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES3YGR><sdc:r_SALES5YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES5YGR><sdc:r_SE><sdc:value>0.00000</sdc:value></sdc:r_SE><sdc:r_TASS3YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS3YGR><sdc:r_TASS5YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS5YGR><sdc:r_TTCFMULT><sdc:value>0.00000</sdc:value></sdc:r_TTCFMULT><sdc:r_TTEBITMULT><sdc:value>0.00000</sdc:value></sdc:r_TTEBITMULT><sdc:r_VALNA><sdc:value>0.00000</sdc:value></sdc:r_VALNA><sdc:sic_SIC><sdc:value sdc:p="0">7319:Advertising, nec</sdc:value><sdc:value sdc:p="1">8742:Management consulting services</sdc:value></sdc:sic_SIC><sdc:upa_UPACIDGEN><sdc:value>595531003</sdc:value></sdc:upa_UPACIDGEN><sdc:upa1_EXCHANGE><sdc:value>Nasdaq</sdc:value></sdc:upa1_EXCHANGE><sdc:upa1_NATION><sdc:value>United States</sdc:value></sdc:upa1_NATION><sdc:upa1_SICP><sdc:value>8742</sdc:value></sdc:upa1_SICP><sdc:upa1_STATE><sdc:value>New Jersey</sdc:value></sdc:upa1_STATE><sdc:upa1_STATUS><sdc:value>Public</sdc:value></sdc:upa1_STATUS><sdc:upa1_TICKER><sdc:value>VTIV</sdc:value></sdc:upa1_TICKER><sdc:upsic_SIC><sdc:value sdc:p="0">7319:Advertising, nec</sdc:value><sdc:value sdc:p="1">8742:Management consulting services</sdc:value></sdc:upsic_SIC><sdc:upt_UPTCIDGEN><sdc:value>1032515001</sdc:value></sdc:upt_UPTCIDGEN><sdc:upt1_NATION><sdc:value>United States</sdc:value></sdc:upt1_NATION><sdc:upt1_SICP><sdc:value>8742</sdc:value></sdc:upt1_SICP><sdc:upt1_STATE><sdc:value>New Jersey</sdc:value></sdc:upt1_STATE><sdc:upt1_STATUS><sdc:value>Private</sdc:value></sdc:upt1_STATUS><sdc:x_RANK1_VALUE><sdc:value>14.50000</sdc:value></sdc:x_RANK1_VALUE><sdc:x_RANK_HOSTRANKVAL><sdc:value>14.50000</sdc:value></sdc:x_RANK_HOSTRANKVAL><sdc:x_RANK_RANKVAL><sdc:value>14.50000</sdc:value></sdc:x_RANK_RANKVAL><sdc:x_rank_rankstgval><sdc:value>7.39300</sdc:value></sdc:x_rank_rankstgval></sdc:deal><category>Deal Information</category><alacra:ip>TF Mergers &amp; Acquisitions</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/spcred/657881</link><guid isPermaLink="false">spcred/657881</guid><spcred:index_mode xmlns:spcred="http://www.alacra.com/spcred">norm</spcred:index_mode><description>The latest Summary from S&amp;P</description><spcred:dataset xmlns:spcred="http://www.alacra.com/spcred">global</spcred:dataset><pubDate>7/3/2008 4:32:22 PM</pubDate><spcred:price xmlns:spcred="http://www.alacra.com/spcred">175</spcred:price><title>Summary: inVentiv Health Inc.</title><spcred:type xmlns:spcred="http://www.alacra.com/spcred">Summary</spcred:type><spcred:docid xmlns:spcred="http://www.alacra.com/spcred">657881</spcred:docid><spcred:index_entry_dispcountry xmlns:spcred="http://www.alacra.com/spcred">United States</spcred:index_entry_dispcountry><spcred:index_entry_dispgics xmlns:spcred="http://www.alacra.com/spcred">Health Care  Services</spcred:index_entry_dispgics><spcred:index_entry_dispregion xmlns:spcred="http://www.alacra.com/spcred">United States</spcred:index_entry_dispregion><spcred:index_entry_dispsector xmlns:spcred="http://www.alacra.com/spcred">Global Issuers</spcred:index_entry_dispsector><spcred:index_entry_dispsector xmlns:spcred="http://www.alacra.com/spcred">Corporations</spcred:index_entry_dispsector><spcred:index_entry_dispsector xmlns:spcred="http://www.alacra.com/spcred">Health Care</spcred:index_entry_dispsector><spcred:index_entry_dispsector xmlns:spcred="http://www.alacra.com/spcred">Retail</spcred:index_entry_dispsector><spcred:index_entry_dispsector xmlns:spcred="http://www.alacra.com/spcred">High Technology</spcred:index_entry_dispsector><spcred:index_entry_disptype xmlns:spcred="http://www.alacra.com/spcred">Summary</spcred:index_entry_disptype><spcred:index_entry_excerpt xmlns:spcred="http://www.alacra.com/spcred">The ratings on Somerset, N.J.-based inVentiv Health Inc. continue to reflect its solid, but niche, position in the pharmaceutical outsourced services industry, the competitive nature of its markets, and the challenges inherent in integrating several acquisitions. These factors partly are offset by its increasingly diverse revenue streams and moderate financial policy. inVentiv provides services to the pharmaceutical industry across four segments. The commercial segment contributed 35% of the company's first quarter 2008 gross revenues, the communications segment contributed 34%, the clinical segment contributed 20%, and the recently created patient outcomes segment contributed 11%. inVentiv's results, especially in the commercial and clinical segments, will rely heavily on pharmaceutical companies' decisions to outsource services, rather than keeping them in-house. In addition, there</spcred:index_entry_excerpt><spcred:index_entry_primcountry xmlns:spcred="http://www.alacra.com/spcred">USA</spcred:index_entry_primcountry><spcred:index_entry_primcusip xmlns:spcred="http://www.alacra.com/spcred">46122E</spcred:index_entry_primcusip><spcred:index_entry_primgics xmlns:spcred="http://www.alacra.com/spcred">35102015 351020 3510 35</spcred:index_entry_primgics><spcred:index_entry_primissuer xmlns:spcred="http://www.alacra.com/spcred">inVentiv Health Inc.</spcred:index_entry_primissuer><spcred:index_entry_primissuerid xmlns:spcred="http://www.alacra.com/spcred">392433</spcred:index_entry_primissuerid><spcred:index_entry_primreg xmlns:spcred="http://www.alacra.com/spcred">USA</spcred:index_entry_primreg><spcred:index_entry_primticker xmlns:spcred="http://www.alacra.com/spcred">VTIV</spcred:index_entry_primticker><spcred:index_entry_reporttype xmlns:spcred="http://www.alacra.com/spcred">SUMMARY</spcred:index_entry_reporttype><spcred:index_entry_sector xmlns:spcred="http://www.alacra.com/spcred">GLOBISS</spcred:index_entry_sector><spcred:index_entry_sector xmlns:spcred="http://www.alacra.com/spcred">CORP</spcred:index_entry_sector><spcred:index_entry_sector xmlns:spcred="http://www.alacra.com/spcred">Health</spcred:index_entry_sector><spcred:index_entry_sector xmlns:spcred="http://www.alacra.com/spcred">Retail</spcred:index_entry_sector><spcred:index_entry_sector xmlns:spcred="http://www.alacra.com/spcred">High</spcred:index_entry_sector><category>Credit &amp; Investment Research</category><alacra:ip>S&amp;P Credit Research</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1826140</link><guid isPermaLink="false">ccbn/T1826140</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good morning, ladies and gentlemen. Welcome to the inVentiv Health, Inc., first-quarter #### conference call. I would like to inform you that this conference is being recorded and that all participants are in listen-only mode. After the speakers' remarks, there will be a question-and-answer period. (OPERATOR INSTRUCTIONS) Before we begin, I would like to read the following regarding forward-looking statements. During the course of this conference call, the Company may make projections or other forward-looking statements regarding the financial performance of the Company. Such forward-looking statements involve known and unknown risk that may cause the Company's performance to differ materially. You are kindly referred to the risk factor and cautionary language contained in the documents that the Company filed with the Securities and Exchange Commission including particularly part #, item #a, of the Company's #### annual report on Form ##-K. It should be noted that the financial and statistical...

</description><pubDate>5/12/2008 11:04:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn"> inVentiv Health, Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 inVentiv Health, Inc. Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">VTIV</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Q1 2008 inVentiv Health, Inc. Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1826140</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1750877</link><guid isPermaLink="false">ccbn/T1750877</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good morning, ladies and gentlemen. Welcome to the inVentiv Health, Inc. fourth-quarter and full-year #### conference call. (OPERATOR INSTRUCTIONS). Before we begin, I would like to read the following forward-looking statement. During the course of this conference call, the Company may make projections or other forward-looking statements regarding the financial performance of the Company. Such forward-looking statements involve known and unknown risks that may cause the Company's performance to differ materially.You will kindly refer to the risk factors and cautionary language contained in the documents that the Company filed with the Securities and Exchange Commission including particularly Part #, Item # of the Company's #### annual report on Form ##-K and Part #, Item #a of the Company's quarterly report on Form ##-Q for second quarter ####. It should be noted that financial and statistical information that is discussed during the call and the reconciliation as non-GAAP financial measures...

</description><pubDate>2/28/2008 5:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn"> inVentiv Health, Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 inVentiv Health, Inc. Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">VTIV</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Q4 2007 inVentiv Health, Inc. Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1750877</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/srp/27494</link><guid isPermaLink="false">srp/27494</guid><srp:index_mode xmlns:srp="http://www.alacra.com/srp">norm</srp:index_mode><description>...Address:### Cottontail Lane, Vantage Court North, Somerset, New Jersey ##### Incorporated:DelawareWeb Site: www.ventiv.comSIC Classification: Management Consulting Services (####) Business Description: inVentiv Health, Inc. is a leading provider of outsourced sales and marketing solutions for the pharmaceutical, biotechnology and life sciences industries. The company offers a broad range of integrated and standalone services, in a context of consultative partnership that identifies strategic goals and applies targeted, tailored solutions. The portfolio of offerings includes: integrated sales force recruitment, training and management; standalone sales force recruitment, training, systems automation and regulatory compliance services; product, sample and literature fulfillment; telemarketing and other marketing support; product/brand management; brand/portfolio analytics and forecasting; market research and intelligence; and strategic and tactical planning. Indices:Russell ####, Russell...

</description><srp:company xmlns:srp="http://www.alacra.com/srp">27494</srp:company><title>inVentiv Health, Inc.</title><srp:cusip xmlns:srp="http://www.alacra.com/srp">46122E105</srp:cusip><srp:ticker xmlns:srp="http://www.alacra.com/srp">VTIV</srp:ticker><pubDate>10/6/2006 12:22:00 PM</pubDate><srp:docid xmlns:srp="http://www.alacra.com/srp">27494</srp:docid><category>Credit &amp; Investment Research</category><alacra:ip>SharkRepellent.net</alacra:ip></item></channel></rss>